Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play
Quick Read AKTS retains full worldwide rights to its alpha-emitting cancer platform, with $517M cash and binary Q1…
How Nestlé is using next-gen tech to target GLP-1 consumers
Nestlé is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity,…
How Nestlé is using next-gen tech to target GLP-1 consumers
Nestlé is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity,…
Roche seeks Japan approval for Elecsys pTau217 Alzheimer’s blood test
KEY POINTSRoche Diagnostics files in Japan for Elecsys pTau217 blood test for Alzheimer’s-related biomarker measurement in plasmaElecsys pTau217…
Citi Bullish on Innovent Biologics’ Dual-Engine Strategy, Names It Top Biotech Pick — BigGo Finance
Innovent Biologics (01801.HK) received strong endorsements from foreign brokerages after announcing its operating data for the first half…
Roche gets second European approval for Alzheimer’s test
ZURICH, May 12 (Reuters) – Swiss drugmaker Roche has received the CE mark – a European regulatory clearance…
BMS claims pharma’s most powerful AI supercomputer. How it stacks up to Lilly’s and Roche’s.
Bristol Myers Squibb said Monday it will deploy an NVIDIA DGX SuperPOD, a prepackaged supercomputing platform that NVIDIA…
Samsung Biologics Acquires Swiss CDMO for approximately $1.8 Billion, Making a Major Push into the Obesity Drug Market — BigGo Finance
Samsung Biologics (207940) is investing approximately 2.7 trillion won (approximately $1.8 billion) to acquire PolyPeptide Group, a global…
Samsung Biologics Acquires Swiss PolyPeptide Group for approximately $1.8 Billion, Targeting Obesity Drug Market — BigGo Finance
Samsung Biologics is making a blockbuster acquisition of PolyPeptide Group AG, a Swiss peptide contract development and manufacturing…
Samsung Biologics Bets $1.8 Billion on ‘K-Obesity Drug’ Play with Swiss PolyPeptide Acquisition — BigGo Finance
Samsung Biologics has thrown its hat into the rapidly growing global obesity treatment market, committing 2.7 trillion won…
UBS strongly resets Lilly stock target
Eli Lilly (LLY) has seen a lot of bullish calls from Wall Street in July. Guggenheim, Truist, Bank…
UK: Novartis agrees to acquire Myricx Bio for up to US$1.5bn
Swiss multinational pharma, Novartis, has agreed to acquire Myricx Bio, a UK-based biotech company developing a new class…